Feldene and Temaz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Feldene (piroxicam) and Temaz (temazepam). Common drug interactions include diarrhoea among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Feldene and Temaz. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Feldene?

Feldene has active ingredients of piroxicam. It is often used in arthritis. eHealthMe is studying from 3,913 Feldene users. Check the latest studies of Feldene.

What is Temaz?

Temaz has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,293 Temaz users. Check the latest studies of Temaz.



On Jul, 13, 2026

22 people who take Feldene and Temaz together, and have interactions are studied.

Feldene and Temaz drug interactions.

What are the common drug interactions of Feldene and Temaz, by gender? *:

female:

  1. Diarrhoea
  2. Epistaxis (bleed from the nose)
  3. Hypertension (high blood pressure)
  4. Blood pressure increased
  5. Cardiac disorder
  6. Migraine (headache)
  7. Type 1 diabetes mellitus
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Anaphylactic reaction (serious allergic reaction)
  10. Cardiac failure congestive

male:

  1. Anaemia (lack of blood)
  2. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  3. Back pain
  4. Blood creatinine increased
  5. Blood immunoglobulin g increased
  6. Bone disorder
  7. Cardiac arrest
  8. Cardiac asthma (wheezing, coughing or shortness of breath due to congestive heart failure)
  9. Cardiac failure congestive
  10. Cardiomegaly (increased size of heart than normal)

What are the common drug interactions of Feldene and Temaz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cardiac disorder
  2. Migraine (headache)
  3. Type 1 diabetes mellitus
  4. Cardiac failure congestive
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Hypoglycaemia (deficiency of glucose in the bloodstream)
  7. Joint injury
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Viral cardiomyopathy (weakness in the muscle of the heart due to viral infection)

30-39:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Electrocardiogram st segment depression
  3. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)

40-49:

n/a

50-59:

  1. Myalgia (muscle pain)
  2. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  3. Blood creatine phosphokinase increased
  4. Chest pain
  5. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)

60+:

  1. Fatigue (feeling of tiredness)
  2. Heart rate increased
  3. Anxiety
  4. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Arthralgia (joint pain)
  7. Arthropathy
  8. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  9. Back pain
  10. Blood creatinine increased

What are the existing conditions these people have? *

  1. Stable Angina (a constant chest pain): 6 people, 27.27%
  2. Multiple Myeloma (cancer of the plasma cells): 6 people, 27.27%
  3. Depression: 6 people, 27.27%
  4. Arrhythmias (irregular heartbeat): 6 people, 27.27%
  5. Weight Loss: 2 people, 9.09%
  6. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 2 people, 9.09%
  7. Post-Traumatic Stress Disorder: 2 people, 9.09%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Feldene and Temaz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Feldene and Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Feldene:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Temaz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Feldene and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temaz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on piroxicam and temazepam (the active ingredients of Feldene and Temaz, respectively), and Feldene and Temaz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: